PLOS
open access
CC BY
integrating single-cell transcriptomics and chromatin accessibility profiling to decipher the molecular landscape of Hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is a prevalent and lethal liver malignancy, characterized by high recurrence rates and limited therapeutic options. Current diagnostic and treatment strategies are hindered by drug resistance and a lack of effective biomarkers for early detection. Methods:
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Platform Trial for Personalized and Adaptive Therapies in Hepatocellular Carcinoma#853805
- Prospective Cohort of Patients With Hepatocellular Carcinoma in France#1293290
- Clinical Intervention Strategy for High-risk Group of Hepatitis B Related Hepatocellular Carcinoma#1323113
- The Overall Survival of Patients With Unresectable HCC in Real-life#878835
- Predictive Biomarkers in Patients With Advanced Hepatocellular Carcinoma Treated With Systemic Therapy#993285
Record · ID 1360121
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive